JENNIFER MUNOZ: Open Payments
NPI 1871324210 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 12 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Corcept Therapeutics | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: GEMTESA, MOUNJARO, Korlym, SHINGRIX, Jornay PM, Auvelity, Xhance, VYEPTI.
Industry payments across TX — which companies pay providers there.
